CSL (ASX:CSL; USOTC:CSLLY), a global biopharma leader, today broke ground for the expansion of its state-of-the-art ...

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Afluria Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...

Whether you're a tech junkie or a casual user who's seen every era of computing, you likely have plenty of old tech ephemera in your home. Maybe it's a desk drawer or closet (or even a tote) filled ...

With 2025 in the books, now is a good opportunity to review the list of top-traded shares by Sharesight investors and assess ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) reported a fourth quarter loss of $1.03 per share and revenue of $7.2 million, as the messenger RNA medicines company ...